Squarepoint Ops LLC Genocea Biosciences, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.91 - $2.67 $49,595 - $69,329	-25,966 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.81 - $5.53 $192,913 - $589,398	-106,582 Reduced 80.41%	25,966 $59,000
Q2 2020 Aug 14, 2020	BUY	$1.66 - $3.06 $196,024 - $361,346	118,087 Added 816.59%	132,548 $305,000
Q1 2020 May 15, 2020	BUY	$1.26 - $2.73 $2,065 - $4,474	1,639 Added 12.78%	14,461 $25,000
Q4 2019 Feb 14, 2020	BUY	$2.05 - $2.82 $26,285 - $36,158	12,822 New	12,822 $27,000
Q3 2019 Nov 14, 2019	SELL	$2.9 - $4.07 $114,338 - $160,467	-39,427 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $136,811 - $264,555	39,427 New	39,427 $155,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.